Companies/KR/226950

올릭스 주식회사 · OliX Pharmaceuticals, Inc.

Income flow

Annual
226950 ANNUAL Income StatementPeriod 2025-12-31Source ANNUAL
Net salesKRW 15B+158% Y/YRevenueKRW 15B+158% Y/Y

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Capital & dividends

Stock splits
  1. 2:12020-12-03